Contrasting mechanisms of intracellular calcium ([Ca2+]i) elevation by angiotensin II (AII) and platelet derived growth factor-BB (PDGF-BB) in human vascular smooth muscle cells (VSMCs).
Clunn
G F
GF
Department of Clinical Pharmacology, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London.
Schachter
M
M
Hughes
A D
AD
D000804:Angiotensin II / Q000494:pharmacology*; D000077214:Becaplermin; D002118:Calcium / Q000378:metabolism*; D002478:Cells, Cultured; D006801:Humans; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D010766:Phosphorylation; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins / Q000494:pharmacology; D012501:Saphenous Vein; D014443:Tyrosine / Q000378:metabolism
D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000804:Angiotensin II; D000077214:Becaplermin; D014443:Tyrosine; D011505:Protein-Tyrosine Kinases; D002118:Calcium